AR092409A1 - Formas cristalinas de 1-(5-(5-(3,5-dicloro-4-fluorofenil)-5-(trifluorometil)-4,5-dihidroisoxazol-3-il)-3h-espiro[azetidin-3,1-isobenzofuran]-1-il)-2-(metilsulfonil)etanona - Google Patents
Formas cristalinas de 1-(5-(5-(3,5-dicloro-4-fluorofenil)-5-(trifluorometil)-4,5-dihidroisoxazol-3-il)-3h-espiro[azetidin-3,1-isobenzofuran]-1-il)-2-(metilsulfonil)etanonaInfo
- Publication number
- AR092409A1 AR092409A1 ARP130103110A ARP130103110A AR092409A1 AR 092409 A1 AR092409 A1 AR 092409A1 AR P130103110 A ARP130103110 A AR P130103110A AR P130103110 A ARP130103110 A AR P130103110A AR 092409 A1 AR092409 A1 AR 092409A1
- Authority
- AR
- Argentina
- Prior art keywords
- approximately
- degrees
- ray diffraction
- diffraction pattern
- dihydroisoxazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Reivindicación 1: Una forma cristalina A de 1-(5-(5-(3,5-dicloro-4-fluorofenil)-5-(trifluorometil)-4,5-dihidroisoxazol-3-il)-3H-espiro[azetidin-3,1-isobenzofuran]-1-il)-2-(metilsulfonil)etanona, caracterizada porque exhibe al menos una de las propiedades siguientes: a) un patrón de difracción de rayos X que tiene picos característicos expresados en grados 2q (± 0,2º) a aproximadamente 17,18, 18,83 y 20,07; b) un patrón de difracción de rayos X que tiene picos característicos expresados en grados 2q (± 0,2º) a aproximadamente 17,18, 18,83 y 20,07, y que además comprende al menos un pico de difracción adicional expresado en grados 2q (± 0,2º) seleccionado del grupo que consiste en picos de aproximadamente 4,70, 9,39, 14,10, 15,70, 19,12, 20,97, 21;42, 22,03, 22,54, 23,62 y 28,42; c) un patrón de difracción de rayos X que tiene picos característicos expresados en grados 2q (± 0,2º) a aproximadamente 17,18, 18,83 y 20,07, y que además comprende al menos un pico de difracción adicional expresado en grados 2q (± 0,2º) a aproximadamente 21,42, 22,54 y 28,42; d) un patrón de difracción de rayos X que tiene picos característicos expresados en grados 2q (± 0,2º) a aproximadamente 17,18, 18,83, 20,07, 21,42, 22,54 y 28,42; e) un espectro de infrarrojos por transformada de Fourier en el intervalo de 1.800 a 600 cm⁻¹ sustancialmente como se muestra en la Figura 2; f) un termograma de calorimetría diferencial de barrido que tiene una única endotermia predominante a aproximadamente 145,53ºC a una velocidad de barrido de 10ºC por minuto, sustancialmente como se muestra en la Figura 3.1; y g) un termograma de calorimetría diferencial de barrido que tiene una única endotermia predominante en el intervalo de 144,01ºC a 146,92ºC a una velocidad de barrido de 10ºC por minuto, sustancialmente como se muestra en la Figura 3.2.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261695410P | 2012-08-31 | 2012-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR092409A1 true AR092409A1 (es) | 2015-04-22 |
Family
ID=49115603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130103110A AR092409A1 (es) | 2012-08-31 | 2013-08-30 | Formas cristalinas de 1-(5-(5-(3,5-dicloro-4-fluorofenil)-5-(trifluorometil)-4,5-dihidroisoxazol-3-il)-3h-espiro[azetidin-3,1-isobenzofuran]-1-il)-2-(metilsulfonil)etanona |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US9200003B2 (es) |
| EP (1) | EP2890699B1 (es) |
| JP (1) | JP6109942B2 (es) |
| KR (1) | KR101736643B1 (es) |
| CN (1) | CN104812758B (es) |
| AR (1) | AR092409A1 (es) |
| AU (1) | AU2013308887B2 (es) |
| BR (1) | BR112015004135B8 (es) |
| CA (1) | CA2881467C (es) |
| CL (1) | CL2015000332A1 (es) |
| CY (1) | CY1120611T1 (es) |
| DK (1) | DK2890699T3 (es) |
| ES (1) | ES2671271T3 (es) |
| HK (1) | HK1209125A1 (es) |
| HR (1) | HRP20180861T1 (es) |
| HU (1) | HUE037667T2 (es) |
| LT (1) | LT2890699T (es) |
| MX (1) | MX351463B (es) |
| NO (1) | NO2931268T3 (es) |
| NZ (1) | NZ704175A (es) |
| PH (1) | PH12015500441B1 (es) |
| PL (1) | PL2890699T3 (es) |
| PT (1) | PT2890699T (es) |
| RS (1) | RS57284B1 (es) |
| RU (1) | RU2614978C2 (es) |
| SI (1) | SI2890699T1 (es) |
| TR (1) | TR201807735T4 (es) |
| WO (1) | WO2014036056A1 (es) |
| ZA (1) | ZA201500728B (es) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2881844A1 (en) * | 2012-09-07 | 2014-03-13 | Zoetis Llc | Spirocyclic derivatives as antiparasitic agents |
| HUE045577T2 (hu) * | 2012-09-07 | 2020-01-28 | Zoetis Services Llc | Spirociklusos izoxazolint tartalmazó parazitaellenes kombinációk |
| WO2014189837A1 (en) * | 2013-05-20 | 2014-11-27 | Zoetis Llc | Long-acting spiro-isoxazoline antiparasitic compositions |
| US10149477B2 (en) | 2014-10-06 | 2018-12-11 | Basf Se | Substituted pyrimidinium compounds for combating animal pests |
| CN107873027A (zh) | 2014-11-06 | 2018-04-03 | 巴斯夫欧洲公司 | 用于防治无脊椎动物害虫的3‑吡啶基杂双环化合物 |
| WO2016162371A1 (en) | 2015-04-07 | 2016-10-13 | Basf Agrochemical Products B.V. | Use of an insecticidal carboxamide compound against pests on cultivated plants |
| WO2016198613A1 (en) | 2015-06-11 | 2016-12-15 | Basf Se | N-(thio)acylimino compounds |
| WO2016198611A1 (en) | 2015-06-11 | 2016-12-15 | Basf Se | N-(thio)acylimino heterocyclic compounds |
| WO2017016883A1 (en) | 2015-07-24 | 2017-02-02 | Basf Se | Process for preparation of cyclopentene compounds |
| CN108137537B (zh) | 2015-10-02 | 2021-07-23 | 巴斯夫欧洲公司 | 作为有害物防治剂的具有2-氯嘧啶-5-基取代基的亚氨基化合物 |
| PL3383183T3 (pl) | 2015-11-30 | 2020-11-16 | Basf Se | Kompozycje zawierające cis-jasmon i bacillus amyloliquefaciens |
| US20190077809A1 (en) | 2016-03-09 | 2019-03-14 | Basf Se | Spirocyclic Derivatives |
| BR112018068042A2 (pt) | 2016-03-11 | 2019-01-08 | Basf Se | métodos para controlar pragas de plantas, material de propagação de planta e uso de um ou mais compostos de fórmula i |
| EA038878B1 (ru) | 2016-04-01 | 2021-11-01 | Басф Се | Бициклические соединения |
| WO2018082962A1 (en) * | 2016-11-02 | 2018-05-11 | Basf Se | Process for preparation of tetrahydrothiophene derivatives |
| RU2019121534A (ru) | 2016-12-16 | 2021-01-18 | Басф Се | Пестицидные соединения |
| WO2018162312A1 (en) | 2017-03-10 | 2018-09-13 | Basf Se | Spirocyclic derivatives |
| WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
| AU2018241406B2 (en) | 2017-03-28 | 2021-11-11 | Basf Se | Pesticidal compounds |
| CN116102580A (zh) | 2017-03-31 | 2023-05-12 | 巴斯夫欧洲公司 | 用于防除动物害虫的嘧啶鎓化合物及其混合物 |
| WO2018192793A1 (en) | 2017-04-20 | 2018-10-25 | Basf Se | Substituted rhodanine derivatives |
| CN110582492A (zh) | 2017-04-26 | 2019-12-17 | 巴斯夫欧洲公司 | 作为农药的取代的琥珀酰亚胺衍生物 |
| WO2018206479A1 (en) | 2017-05-10 | 2018-11-15 | Basf Se | Bicyclic pesticidal compounds |
| WO2018224455A1 (en) | 2017-06-07 | 2018-12-13 | Basf Se | Substituted cyclopropyl derivatives |
| EP3638677A1 (en) | 2017-06-16 | 2020-04-22 | Basf Se | Mesoionic imidazolium compounds and derivatives for combating animal pests |
| CN110678469B (zh) | 2017-06-19 | 2023-03-03 | 巴斯夫欧洲公司 | 用于防除动物害虫的取代嘧啶鎓化合物和衍生物 |
| WO2018234488A1 (en) | 2017-06-23 | 2018-12-27 | Basf Se | SUBSTITUTED CYCLOPROPYL DERIVATIVES |
| WO2019042932A1 (en) | 2017-08-31 | 2019-03-07 | Basf Se | METHOD FOR CONTROLLING RICE PARASITES IN RICE |
| EP3453706A1 (en) | 2017-09-08 | 2019-03-13 | Basf Se | Pesticidal imidazole compounds |
| CN111201227B (zh) | 2017-10-13 | 2024-03-15 | 巴斯夫欧洲公司 | 用于防除动物害虫的咪唑烷嘧啶鎓化合物 |
| JP2021503465A (ja) * | 2017-11-16 | 2021-02-12 | アビスタ ファーマ ソリューションズ，インコーポレーテッド | 単一エナンチオマーの抗寄生生物化合物 |
| IL275339B2 (en) | 2017-12-15 | 2024-03-01 | Tarsus Pharmaceuticals Inc | Parasitic formulations containing isoxazoline and methods for treating blepharitis |
| WO2019121143A1 (en) | 2017-12-20 | 2019-06-27 | Basf Se | Substituted cyclopropyl derivatives |
| JP7285844B2 (ja) | 2017-12-21 | 2023-06-02 | ビーエーエスエフ ソシエタス・ヨーロピア | 殺生物剤化合物 |
| BR112020012706A2 (pt) | 2018-01-09 | 2020-11-24 | Basf Se | uso de um composto de silietinil hetarila, composição para uso na redução de nitrificação, mistura agroquímica, métodos para reduzir a nitrificação e para tratamento de um fertilizante ou de uma composição |
| WO2019137995A1 (en) | 2018-01-11 | 2019-07-18 | Basf Se | Novel pyridazine compounds for controlling invertebrate pests |
| EP3759097A1 (en) | 2018-02-28 | 2021-01-06 | Basf Se | Use of n-functionalized alkoxy pyrazole compounds as nitrification inhibitors |
| KR20200128052A (ko) | 2018-02-28 | 2020-11-11 | 바스프 에스이 | 질화작용 저해제로서의 알콕시피라졸의 용도 |
| US11498885B2 (en) | 2018-02-28 | 2022-11-15 | Basf Se | Use of pyrazole propargyl ethers as nitrification inhibitors |
| WO2019175713A1 (en) | 2018-03-14 | 2019-09-19 | Basf Corporation | New catechol molecules and their use as inhibitors to p450 related metabolic pathways |
| WO2019175712A1 (en) | 2018-03-14 | 2019-09-19 | Basf Corporation | New uses for catechol molecules as inhibitors to glutathione s-transferase metabolic pathways |
| WO2019185413A1 (en) | 2018-03-27 | 2019-10-03 | Basf Se | Pesticidal substituted cyclopropyl derivatives |
| JP7433244B2 (ja) | 2018-05-15 | 2024-02-19 | ビーエーエスエフ ソシエタス・ヨーロピア | ベンズピリモキサン及びオキサゾスルフィルを含む混合物並びにその使用及び施用方法 |
| WO2019224092A1 (en) | 2018-05-22 | 2019-11-28 | Basf Se | Pesticidally active c15-derivatives of ginkgolides |
| WO2020002472A1 (en) | 2018-06-28 | 2020-01-02 | Basf Se | Use of alkynylthiophenes as nitrification inhibitors |
| DK3826982T3 (da) | 2018-07-23 | 2024-01-22 | Basf Se | Anvendelse af en substitueret thiazolidinforbindelse som nitrificeringshæmmer |
| CA3104256A1 (en) | 2018-07-23 | 2020-01-30 | Basf Se | Use of substituted 2-thiazolines as nitrification inhibitors |
| EP3613736A1 (en) | 2018-08-22 | 2020-02-26 | Basf Se | Substituted glutarimide derivatives |
| EP3628156A1 (en) | 2018-09-28 | 2020-04-01 | Basf Se | Method for controlling pests of sugarcane, citrus, rapeseed, and potato plants |
| EP3628157A1 (en) | 2018-09-28 | 2020-04-01 | Basf Se | Method of controlling insecticide resistant insects and virus transmission to plants |
| BR112021004526A2 (pt) | 2018-09-28 | 2021-06-08 | Basf Se | uso do composto, métodos de proteção de plantas, de controle ou combate a pragas invertebradas e de tratamento de sementes e semente |
| EP3628158A1 (en) | 2018-09-28 | 2020-04-01 | Basf Se | Pesticidal mixture comprising a mesoionic compound and a biopesticide |
| EP3643705A1 (en) | 2018-10-24 | 2020-04-29 | Basf Se | Pesticidal compounds |
| EP3887357A1 (en) | 2018-11-28 | 2021-10-06 | Basf Se | Pesticidal compounds |
| WO2020126591A1 (en) | 2018-12-18 | 2020-06-25 | Basf Se | Substituted pyrimidinium compounds for combating animal pests |
| EP3696177A1 (en) | 2019-02-12 | 2020-08-19 | Basf Se | Heterocyclic compounds for the control of invertebrate pests |
| EP3769623A1 (en) | 2019-07-22 | 2021-01-27 | Basf Se | Mesoionic imidazolium compounds and derivatives for combating animal pests |
| WO2020239517A1 (en) | 2019-05-29 | 2020-12-03 | Basf Se | Mesoionic imidazolium compounds and derivatives for combating animal pests |
| EP3766879A1 (en) | 2019-07-19 | 2021-01-20 | Basf Se | Pesticidal pyrazole derivatives |
| WO2022061914A1 (zh) * | 2020-09-28 | 2022-03-31 | 台州臻挚生物科技有限公司 | 一种3,5-二卤三氟苯乙酮及其衍生物的制备方法 |
| AU2022216425A1 (en) | 2021-02-02 | 2023-08-17 | Basf Se | Synergistic action of dcd and alkoxypyrazoles as nitrification inhibitors |
| WO2022243523A1 (en) | 2021-05-21 | 2022-11-24 | Basf Se | Use of an n-functionalized alkoxy pyrazole compound as nitrification inhibitor |
| BR112023024012A2 (pt) | 2021-05-21 | 2024-02-06 | Basf Se | Uso de composto de etinilpiridina, composição para uso na redução da nitrificação, mistura agroquímica e métodos de redução da nitrificação e de tratamento de fertilizante ou composição |
| BR112023027004A2 (pt) | 2021-06-21 | 2024-03-12 | Basf Se | Estrutura de metal-orgânica, uso da estrutura de metal-orgânica, composição para uso na redução da nitrificação, mistura agroquímica e métodos de redução da nitrificação, de tratamento de fertilizante ou composição de fertilizante e de preparação de uma estrutura de metal-orgânica |
| WO2022271933A1 (en) | 2021-06-23 | 2022-12-29 | Kimtron, Inc. | System and method for ultra-close proximity irradiation of rotating biomass |
| WO2023203066A1 (en) | 2022-04-21 | 2023-10-26 | Basf Se | Synergistic action as nitrification inhibitors of dcd oligomers with alkoxypyrazole and its oligomers |
| WO2024028243A1 (en) | 2022-08-02 | 2024-02-08 | Basf Se | Pyrazolo pesticidal compounds |
| CN117263825A (zh) * | 2023-11-23 | 2023-12-22 | 内蒙古百灵科技有限公司 | 一种双甲脒结晶的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1007310A2 (pt) * | 2009-01-22 | 2015-08-25 | Syngenta Participations Ag | Compostos inseticidas. |
| MX2012009707A (es) * | 2010-02-25 | 2012-09-12 | Syngenta Ltd | Proceso para preparar derivados isoxazolinicos. |
| JP5409968B2 (ja) * | 2010-08-05 | 2014-02-05 | ゾエティス・エルエルシー | 駆虫剤としてのイソオキサゾリン誘導体 |
| WO2012086462A1 (ja) * | 2010-12-20 | 2012-06-28 | 日本曹達株式会社 | イソオキサゾリン化合物および有害生物防除剤 |
| BR112013023068B8 (pt) * | 2011-03-10 | 2022-11-22 | Zoetis Llc | Derivados de isoxazolina espirocíclica, seu uso e seu processo de preparação, e composições veterinárias |
-
2013
- 2013-08-28 RS RS20180636A patent/RS57284B1/sr unknown
- 2013-08-28 LT LTEP13756985.1T patent/LT2890699T/lt unknown
- 2013-08-28 DK DK13756985.1T patent/DK2890699T3/en active
- 2013-08-28 EP EP13756985.1A patent/EP2890699B1/en active Active
- 2013-08-28 CA CA2881467A patent/CA2881467C/en active Active
- 2013-08-28 US US14/422,098 patent/US9200003B2/en active Active
- 2013-08-28 PT PT137569851T patent/PT2890699T/pt unknown
- 2013-08-28 AU AU2013308887A patent/AU2013308887B2/en active Active
- 2013-08-28 NZ NZ704175A patent/NZ704175A/en unknown
- 2013-08-28 JP JP2015529970A patent/JP6109942B2/ja active Active
- 2013-08-28 WO PCT/US2013/056945 patent/WO2014036056A1/en active Application Filing
- 2013-08-28 RU RU2015107052A patent/RU2614978C2/ru active
- 2013-08-28 MX MX2015002679A patent/MX351463B/es active IP Right Grant
- 2013-08-28 ES ES13756985.1T patent/ES2671271T3/es active Active
- 2013-08-28 KR KR1020157004953A patent/KR101736643B1/ko active IP Right Grant
- 2013-08-28 CN CN201380044821.9A patent/CN104812758B/zh active Active
- 2013-08-28 TR TR2018/07735T patent/TR201807735T4/tr unknown
- 2013-08-28 BR BR112015004135A patent/BR112015004135B8/pt active IP Right Grant
- 2013-08-28 PL PL13756985T patent/PL2890699T3/pl unknown
- 2013-08-28 SI SI201331062T patent/SI2890699T1/en unknown
- 2013-08-28 HU HUE13756985A patent/HUE037667T2/hu unknown
- 2013-08-30 AR ARP130103110A patent/AR092409A1/es unknown
- 2013-12-13 NO NO13863231A patent/NO2931268T3/no unknown
-
2015
- 2015-01-30 ZA ZA2015/00728A patent/ZA201500728B/en unknown
- 2015-02-11 CL CL2015000332A patent/CL2015000332A1/es unknown
- 2015-02-27 PH PH12015500441A patent/PH12015500441B1/en unknown
- 2015-10-12 HK HK15109932.5A patent/HK1209125A1/xx unknown
-
2018
- 2018-05-30 HR HRP20180861TT patent/HRP20180861T1/hr unknown
- 2018-06-13 CY CY181100619T patent/CY1120611T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR092409A1 (es) | Formas cristalinas de 1-(5-(5-(3,5-dicloro-4-fluorofenil)-5-(trifluorometil)-4,5-dihidroisoxazol-3-il)-3h-espiro[azetidin-3,1-isobenzofuran]-1-il)-2-(metilsulfonil)etanona | |
| PH12016501972A1 (en) | Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors | |
| DOP2016000281A (es) | Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer | |
| CU20170087A7 (es) | Formas cristalinas de 5-(4-ciclopropil-1 h-imidazol-1-il)-n-(6-(4-isopropil-4h-1 , 2, 4- triazol-3-il)piridin-2-il)-2-fluoro-4-metilbenzamida | |
| AR101403A1 (es) | (4s)-4-(4-ciano-2-metoxifenilo)-5-etoxi-2,8-dimetilo-1,4-dihidro-1,6-naftiridin-3-carboxamida, su purificación para su uso como principio activo farmacéutico, un procedimiento para su preparación y su empleo en el tratamiento de enfermedades cardiovasculares | |
| CR20150472A (es) | USO DE DERIVADOS DE PIRAZOLOPIRIMIDINA PARA EL TRATAMIENTO DE TRANSTORNOS RELACIONADOS CON LA PI3Kd | |
| CO2017001884A2 (es) | Polimorfos de selinexor | |
| EA201790766A1 (ru) | Новые соединения метилпиперидина, подходящие для ингибирования микросомальной простагландин-e2-синтазы 1 | |
| AR106612A1 (es) | Sales, formas cristalinas y composiciones farmacéuticas de 4-[2-(4-amino-piperidin-1-il)-5-(3-fluoro-4-metoxi-fenil)-1-metil-6-oxo-1,6-dihidro-pirimidin-4-il]-2-fluorobenzonitrilo como inhibidor de demetilasa 1 específica de lisina | |
| CL2016000466A1 (es) | Compuestos derivados de 2-amino pirimidina sustituida, inhibidores de bmi-1 composicion farmaceutica y uso en el tratamiento del cancer. | |
| TW201613872A (en) | IRAK4 inhibiting agents | |
| UY34480A (es) | Compuestos de 2-(fenilo sustituido)-ciclopentan-1,3-diona y derivados de los mismos, composiciones y métodos para controlar malezas. | |
| CR20140084A (es) | Derivados de 2-amino-4-(piridin-2-il)-5,6-dihidro-4h-1,3-oxazina y su uso como inhibidores de bace-1 y/o bace-2 | |
| CL2015001377A1 (es) | Inhbibidores de bmi-1 primidinas sustituidas inversas | |
| EA201791305A1 (ru) | Конденсированные пиримидины для лечения вич | |
| DOP2016000308A (es) | Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer | |
| CL2015002606A1 (es) | Compuesto. | |
| CO2017001528A2 (es) | Compuestos novedosos de pirimidina sustituidos | |
| CO2017001506A2 (es) | Compuestos novedosos de pirimidina sustituidos | |
| EA201891050A1 (ru) | Соединения пирроло-, пиразоло-, имидазопиримидина и пиридина, которые ингибируют mnk1 и mnk2 | |
| MD20170011A2 (ro) | Compuşi imidazopiridazinici | |
| CL2016000496A1 (es) | Compuestos derivados de 1,2,4-triazolo[1,5-a]-piridina, inhibidores de una janus cinasa, tal como jak1; composiciones farmacológicas; útiles para el tratamiento de enfermedades inflamatorias. | |
| CO2017001523A2 (es) | Novedosas pirimidinas 2,5-sustituidas | |
| UY35393A (es) | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a | |
| EA201491227A1 (ru) | Новые производные морфолинила, подходящие для применения в качестве ингибиторов mogat-2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |